Breaking News Instant updates and real-time market news.

MGLN

Magellan Health

$68.90

0.8 (1.17%)

08:55
11/22/16
11/22
08:55
11/22/16
08:55

Magellan Health to hold a conference call

Chairman & CEO Smith holds a 2017 financial guidance conference call to be held on November 22 at 9 am. Webcast Link

  • 22

    Nov

MGLN Magellan Health
$68.90

0.8 (1.17%)

01/06/16
01/06/16
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: American Capital Mortgage (MTGE) downgraded to Neutral at Credit Suisse... AmerisourceBergen (ABC) downgraded to Market Perform from Outperform at Raymond James... Apple (AAPL) downgraded to Neutral from Buy at Rosenblatt... Becton Dickinson (BDX) downgraded to Hold from Buy at Evercore ISI... CBL & Associates (CBL) downgraded to Neutral from Buy at Goldman... Cardinal Health (CAH) downgraded to Market Perform from Outperform at Raymond James... Check Point (CHKP) downgraded to Underweight from Equal Weight at Barclays... Choice Hotels (CHH) downgraded to Underweight from Neutral at JPMorgan... Community Health (CYH) downgraded to Underperform at Raymond James... Cornerstone OnDemand (CSOD) downgraded to Underweight from Overweight at Barclays... Demandware (DWRE) downgraded to Equal Weight from Overweight at Barclays... Fortune Brands (FBHS) downgraded to Neutral from Outperform at Macquarie... HCA Holdings (HCA) downgraded to Market Perform from Outperform at Leerink... HCP (HCP) downgraded to Underweight from Equal Weight at Barclays... HSBC (HSBC) downgraded to Underweight from Neutral at JPMorgan... Hyatt (H) downgraded to Neutral from Overweight at JPMorgan... Karyopharm (KPTI) downgraded to Hold from Buy at Jefferies... Magellan Health (MGLN) downgraded to Underweight from Equal Weight at Barclays... Masimo (MASI) downgraded to Outperform from Strong Buy at Raymond James... McKesson (MCK) downgraded to Outperform from Strong Buy at Raymond James... PNC Financial (PNC) downgraded to Neutral from Buy at Nomura... Publicis (PUBGY) downgraded to Underperform from Neutral at Exane BNP Paribas... Qlik Technologies (QLIK) downgraded to Sector Weight from Overweight at Pacific Crest... Ring Energy (REI) downgraded to Market Perform from Outperform at FBR Capital... Rite Aid (RAD) downgraded to Hold from Buy at Evercore ISI... Rush Enterprises (RUSHA) downgraded to Neutral from Buy at Longbow... Smith & Wesson (SWHC) downgraded to Neutral from Outperform at Wedbush... Stone Energy (SGY) downgraded to Market Perform from Outperform at FBR Capital... Stonegate Mortgage (SGM) downgraded to Neutral from Outperform at Credit Suisse... Teradata (TDC) downgraded to Underweight from Equal Weight at Barclays... Tyco (TYC) downgraded to Sector Perform from Outperform at RBC Capital... UniCredit (UNCFF) downgraded to Underweight from Neutral at JPMorgan... United Technologies (UTX) downgraded to Neutral from Buy at Sterne Agee CRT... Vanguard Natural (VNR) downgraded to Neutral from Overweight at JPMorgan... WESCO (WCC) downgraded to Sector Perform from Outperform at RBC Capital... Workday (WDAY) downgraded to Equal Weight from Overweight at Barclays.
06/03/16
LEER
06/03/16
NO CHANGE
Target $60
LEER
Market Perform
Magellan Health price target raised to $60 from $50 at Leerink
Leerink analyst Ana Gupte raised her price target for Magellan Health to $60 from $50 after a good quarter with a "meaningful" top and bottom line beat. While contract loss in Healthcare remains a downside risk, the company's Pharmacy segment is an offset with less risk to earnings achievability, the analyst tells investors in a research note, adding that the purchase of the Armed Forces Services Corporation Business also offers upside in 2016 and into 2017. Gupte reiterates a Market Perform on the shares.
06/29/16
KEYB
06/29/16
INITIATION
KEYB
Sector Weight
Magellan Health initiated with a Sector Weight at KeyBanc
09/26/16
JEFF
09/26/16
NO CHANGE
Target $76
JEFF
Buy
Magellan Health shares have 40% upside, says Jefferies
Jefferies analyst David Styblo views Magellan Health as "significantly undervalued" following the stock's 25% pullback since late July. The biggest investor concern centers on the steeper than usual earnings ramp in the second half of the year in order to achieve guidance, Styblo tells investors in a research note. He believes Magellan will achieve its guidance and sees 40% upside in the shares. The analyst lowered his price target for Magellan to $76 from $86 and keeps a Buy rating on the shares.

TODAY'S FREE FLY STORIES

07:20
01/23/18
01/23
07:20
01/23/18
07:20
General news
Treasury Market Outlook: global yields tracked lower overnight »

Treasury Market Outlook:…

07:18
01/23/18
01/23
07:18
01/23/18
07:18
Conference/Events
Federal Reserve Bank of Chicago President participates in a discussion »

Chicago Federal Reserve…

STT

State Street

$108.99

1.38 (1.28%)

07:17
01/23/18
01/23
07:17
01/23/18
07:17
Hot Stocks
State Street sees Beacon savings realized 18 months ahead of plan by mid-2019 »

In slides ahead of its Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

07:17
01/23/18
01/23
07:17
01/23/18
07:17
Conference/Events
The Chicago Council on Global Affairs to hold a panel discussion »

The Chicago Council on…

W

Wayfair

$90.64

2.8 (3.19%)

07:17
01/23/18
01/23
07:17
01/23/18
07:17
Downgrade
Wayfair rating change  »

Wayfair downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

07:16
01/23/18
01/23
07:16
01/23/18
07:16
Conference/Events
CFA Society of Columbus to hold a dinner meeting »

Ian Wallace of Third…

VYGR

Voyager Therapeutics

$20.23

1.56 (8.36%)

07:13
01/23/18
01/23
07:13
01/23/18
07:13
Hot Stocks
Voyager Therapeutics announces FDA clearance of VY-AADC IND application »

Voyager Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TBK

Triumph Bancorp

$37.00

1 (2.78%)

07:13
01/23/18
01/23
07:13
01/23/18
07:13
Upgrade
Triumph Bancorp rating change  »

Triumph Bancorp upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

07:13
01/23/18
01/23
07:13
01/23/18
07:13
Conference/Events
Boston University to release survey »

Boston University…

CAT

Caterpillar

$170.89

0.48 (0.28%)

07:12
01/23/18
01/23
07:12
01/23/18
07:12
Upgrade
Caterpillar rating change  »

Caterpillar upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

GPRO

GoPro

$6.30

0.01 (0.16%)

07:12
01/23/18
01/23
07:12
01/23/18
07:12
Downgrade
GoPro rating change  »

GoPro downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

VZ

Verizon

$53.46

1.55 (2.99%)

07:11
01/23/18
01/23
07:11
01/23/18
07:11
Periodicals
Verizon mulls sports gambling as legalization nears, Bloomberg reports »

Verizon is mulling…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Jan

SRNE

Sorrento Therapeutics

$7.75

1.35 (21.09%)

, JUNO

Juno Therapeutics

$86.00

18.19 (26.83%)

07:10
01/23/18
01/23
07:10
01/23/18
07:10
Recommendations
Sorrento Therapeutics, Juno Therapeutics, Celgene analyst commentary  »

Juno acquisition bodes…

SRNE

Sorrento Therapeutics

$7.75

1.35 (21.09%)

JUNO

Juno Therapeutics

$86.00

18.19 (26.83%)

CELG

Celgene

$102.91

0.26 (0.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jan

  • 25

    Jan

  • 29

    Jan

  • 16

    Feb

  • 28

    Feb

  • 25

    Mar

SPX

S&P 500

07:10
01/23/18
01/23
07:10
01/23/18
07:10
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENLC

EnLink Midstream

$19.25

0.5 (2.67%)

, ENLK

EnLink Midstream Partners

$18.08

0.63 (3.61%)

07:10
01/23/18
01/23
07:10
01/23/18
07:10
Conference/Events
U.S. Capital Advisors to hold a conference »

Midstream Corporate…

ENLC

EnLink Midstream

$19.25

0.5 (2.67%)

ENLK

EnLink Midstream Partners

$18.08

0.63 (3.61%)

TRGP

Targa Resources

$51.00

0.27 (0.53%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 26

    Feb

ACBFF

Aurora Cannabis

$11.65

0.8799 (8.17%)

07:10
01/23/18
01/23
07:10
01/23/18
07:10
Hot Stocks
Aurora Cannabis, CanniMed extending standstill agreement »

CanniMed Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GDX

Market Vector Gold Miners

$23.71

0.06 (0.25%)

07:09
01/23/18
01/23
07:09
01/23/18
07:09
Technical Analysis
Market Vector Gold Miners: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VZ

Verizon

$53.46

1.55 (2.99%)

07:09
01/23/18
01/23
07:09
01/23/18
07:09
Hot Stocks
Breaking Hot Stocks news story on Verizon »

Verizon up marginally…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Jan

AOS

A.O. Smith

$67.00

-0.04 (-0.06%)

, JCI

Johnson Controls

$39.20

0.3 (0.77%)

07:09
01/23/18
01/23
07:09
01/23/18
07:09
Conference/Events
KeyBanc to hold company meetings at expo »

KeyBanc Company Meetings…

AOS

A.O. Smith

$67.00

-0.04 (-0.06%)

JCI

Johnson Controls

$39.20

0.3 (0.77%)

RBC

Regal Beloit

$79.20

-0.2 (-0.25%)

WTS

Watts Water

$79.65

-0.85 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 30

    Jan

  • 31

    Jan

  • 06

    Feb

  • 13

    Feb

  • 22

    Feb

VZ

Verizon

$53.46

1.55 (2.99%)

07:09
01/23/18
01/23
07:09
01/23/18
07:09
Hot Stocks
Verizon sees positive impact to cash flow from operations from tax reform »

Tax-reform legislation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 25

    Jan

GLD

SPDR Gold Trust

$126.65

0.23 (0.18%)

07:09
01/23/18
01/23
07:09
01/23/18
07:09
Technical Analysis
SPDR Gold Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:08
01/23/18
01/23
07:08
01/23/18
07:08
Conference/Events
Goldman Sachs to hold a conference »

Fintech Conference 2018…

NUGT

Direxion Gold Miners Bull

$32.99

0.15 (0.46%)

07:08
01/23/18
01/23
07:08
01/23/18
07:08
Technical Analysis
Direxion Gold Miners Bull: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JPM

JPMorgan

$114.33

1.32 (1.17%)

07:08
01/23/18
01/23
07:08
01/23/18
07:08
Hot Stocks
Breaking Hot Stocks news story on JPMorgan »

JPMorgan hiring 4,000…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

PG

Procter & Gamble

$91.89

0.82 (0.90%)

07:08
01/23/18
01/23
07:08
01/23/18
07:08
Earnings
Procter & Gamble raises FY18 core EPS growth view to 5%-8% from 5%-7% »

P&G said it is…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 16

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.